期刊
DRUG DEVELOPMENT RESEARCH
卷 74, 期 2, 页码 92-111出版社
WILEY
DOI: 10.1002/ddr.21073
关键词
Alzheimer's disease; biomarkers; pathogenesis
资金
- SRI International internal research and development funds
Preclinical Research Alzheimer's disease (AD) is a complex, progressive, and eventually fatal neurodegenerative disease that currently lacks effective treatment options. The disease process is only partially understood. Biomarker identification and analysis will be important for facilitating a deeper understanding of the molecular nature of the disease process and neuropathology, diagnosis of the disease at its earliest stages, in assessing disease progression and to enable the drug discovery and development process. This review assesses progress in a number of areas of AD biomarker discovery and development, constituting a potential systems approach to understanding and diagnosing this disease, including next-generation DNA sequencing of human genomes, genome-wide association studies, epigenetics (including DNA methylation and micro-RNA profiling), gene expression profiling, lipidomics and metabolomics, proteomics, and neuroimaging.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据